Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study

PURPOSEOur investigation assessed the impact of geographical disparities in the treatment of patients with advanced urothelial cancer (aUC) included in the international, real-world ARON-2 trial.PATIENTS AND METHODSThe study population comprised 1,137 patients with aUC treated with pembrolizumab for...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mimma Rizzo, Andrey Soares, Shilpa Gupta, Fabio Calabrò, Hideki Takeshita, Maria Teresa Bourlon, Se Hoon Park, Patrizia Giannatempo, Zin War Myint, Thomas Büttner, Enrique Grande, Ondrej Fiala, Daniele Santini, Aristotelis Bamias, Roubini Zakopoulou, Sebastiano Buti, Ravindran Kanesvaran, Pasquale Rescigno, Javier Molina-Cerrillo, Ilana Epstein, Fernando Sabino Marques Monteiro, Francesco Massari, Camillo Porta, Joaquin Bellmunt, Matteo Santoni
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society of Clinical Oncology 2025-07-01
coleção:	JCO Global Oncology
Acesso em linha:	https://ascopubs.org/doi/10.1200/GO-24-00564
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!